Myriad Genetics (MYGN) Total Debt Growth (1y) (2017 - 2026)
Myriad Genetics (MYGN) Total Debt Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 22.57% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 56.63% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -0.06% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | -4.01% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 3.29% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | -20.41% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -0.07% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | -3.29% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 15.39% |
| 10 | Myriad Genetics | 300.99 Mn | 185.79 Mn | 127.00 Mn | 103.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 103.20% |
| Mar 31, 2026 | 102.87% |
| Dec 31, 2025 | 202.78% |
| Sep 30, 2025 | 206.41% |
| Jun 30, 2025 | 53.09% |
| Mar 31, 2025 | 53.23% |
| Dec 31, 2024 | 2.86% |
| Sep 30, 2024 | 1.30% |
| Jun 30, 2024 | 1.04% |
| Jun 30, 2021 | -8.48% |
| Mar 31, 2021 | -32.54% |
| Dec 31, 2020 | -1.62% |
| Sep 30, 2020 | -0.18% |
| Jun 30, 2020 | -3.97% |
| Mar 31, 2020 | -14.53% |
| Dec 31, 2019 | -17.98% |
| Sep 30, 2019 | -13.29% |
| Jun 30, 2019 | 1,522.60% |
| Mar 31, 2019 | 248.24% |
| Dec 31, 2018 | 146.11% |